The safety profile of fluvoxamine in elderly patients

Human Psychopharmacology

Volumn 11, Issue 4, 1996, Pages 267-272

  Wagner, Wolfgang ^a   Houser, Vincent ^b   Wong, Lung Fai ^b  

^a Solvay Pharmaceuticals GmbH   (Germany)

^b Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

Antidepressant; Elderly; Fluvoxamine; Safety; Selective serotonin reuptake inhibitor; Tolerability

Indexed keywords

ANTIDEPRESSANT AGENT; BROMAZEPAM; CLORAZEPATE DIPOTASSIUM; FLUVOXAMINE; LORAZEPAM; SEROTONIN UPTAKE INHIBITOR;

AGED; AGING; AGITATION; ANOREXIA; ARTICLE; CLINICAL PROTOCOL; DEPRESSION; DOSE RESPONSE; DRUG OVERDOSE; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; GOOD CLINICAL PRACTICE; HEADACHE; HEART INFARCTION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALAISE; MALE; NAUSEA; NERVOUSNESS; PRIORITY JOURNAL; SOMNOLENCE; SUICIDE; TREMOR; XEROSTOMIA;

EID: 0029781956     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199607)11:4<267::AID-HUP808>3.0.CO;2-9     Document Type: Article

References (15)

1. Ashford, J. J. and Rahman, K. (1990). Fluvoxamine versus dothiepin: a double-blind study in the elderly depressed patients. Journal of Psychopharmacology, 4, 299.
2. Coding Symbols for Thesaurus of Adverse Reaction Terms (1989). FDA Center for Drug Evaluation and Research, Rockville, Maryland, USA.
3. Crome. P. (1984). ABC of poisoning: the elderly. British Medical Journal, 289, 546-548.
4. Edwards, J. G., Inman, W. H. W., Wilton, L. and Pearce, G. L. (1994). Prescription-event monitoring of 10 401 patients treated with fluvoxamine. British Journal of Psychiatry, 164, 387-395.
5. Freeman. C. P. L., Trimble, M. R., Deakin, J. F. W., Stokes, T. M. and Ashford, J. J. (1994). Fluvoxamine versus clomipramine in the treatment of obsessive-compulsive disorder. A multicenter, randomized, double-blind, parallel-group comparison. Journal of Clinical Psychiatry, 55, 301-305.
6. Koenig, H. G., Meador, K. G., Cohen, H. J. and Blazer, D. G. (1988). Depression in elderly hospitalized patients with medical illness. Archives of Internal Medicine, 148, 1929-1936.
7. Parmelee, P. A., Katz, I. R. and Lawton, M. P. (1989). Depression among institutionalised aged. Assessment and prevalence estimation. Journal of Gerontology, 44, 1722-1729.
8. Phanjoo, A. L., Wonnacott, S. and Hodgson, A. (1991). A double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people. Acta Psychiatrica Scandinavica, 83, 476-479.
9. Rahman, M. K., Akhtar, M. J., Savla, N. C., Sharma, R. R., Kellett, J. M. and Ashford, J. J. (1991). A double-blind randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients. British Journal of Clinical Practice, 45, 255-258.
10. Roseman, J. (1981). Mortality and morbidity overview. Clinical Geriatrics, 38, 1264-1344.
11. Tebbs, V. M. and Martin, A. J. (1987). Affective disorders in the elderly: 1000 patient GP trial on new drug. Geriatric Medicine, 17, 17-21.
12. Wagner, W., Zaborny, B. A. and Gray, T. E. (1994). Fluvoxamine. A review of its safety profile in worldwide studies. International Clinical Psychopharmacology, 9, 222-226.
13. Wakelin, J. S. (1986). Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data. International Clinical Psychopharmacology, 1, 221-230.
14. Wakelin, J. S. (1988). The role of serotonin in depression and suicide. Advances in Biological Psychiatry, 17, 70-83.
15. Wilde, M. I., Plosker, G. L. and Benfield, P. (1993). Fluvoxamine. An updated review of its pharmacology and therapeutic use in depressive illness. Drugs, 46, 895-924.